- RYTM -1.63%
While Rhythm Pharmaceuticals (NASDAQ:RYTM) shareholders have made 125% in 1 year, increasing losses might now be front of mind as stock sheds 3.2% this week
Yahoo Finance · 2 days ago
Open | 37.65 |
High | 37.97 |
Low | 36.74 |
Mkt Cap | 2.24B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 37.37 |
52 Wk. Low | 15.50 |
52 Wk. High | 52.57 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 25.97M | 126.40% ▲ |
Net Income | -141.37M | - |
Diluted EPS | -2.35 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.71 | - |
Q1 2024 | -$2.16 | -$2.35 |
Q4 2023 | -$0.70 | -$0.70 |
S&P 500^GSPC | 5,304.72+36.88 (+0.70%) |
Dow 30^DJI | 39,069.59+4.29 (+0.01%) |
Nasdaq^IXIC | 16,920.79+184.79 (+1.10%) |
Bitcoin USDBTC-USD | 68,835.57-0.52% |
UiPath Inc.PATH | 18.98-0.32% |
7.21-2.83% |